American Dental Association Providers Clinical Support System on Opioid Therapies Webinar
|
|
|
- Veronica Dalton
- 8 years ago
- Views:
Transcription
1 American Dental Association Providers Clinical Support System on Opioid Therapies Webinar Friday, May 23, :00 PM (CDT) Funding for this initiative was made possible (in part) by Providers' Clinical Support System for Opioid Therapies (1H79TI023439) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
2 How to Discuss Drug Issues with a Patient Greg L. Jones, MD Medical Director Kentucky Physicians Health Foundation Diplomate-ABAM, ABFM
3 Faculty Disclosure Dr. Jones has no financial relationships to disclose Dr. Jones is a full time employee of the Kentucky Physicians Health Foundation Dr. Jones will not be speaking about off label uses of drugs or devices
4 Needs Statement Many healthcare professionals are uncomfortable discussing alcohol and drug use with their patients Optimal healthcare requires this information for good clinical decisions All providers need to improve their comfort and skill set in having these discussions
5 And Addiction is a common disease-as high as 15% in most studies It is frequently diagnosed late or not at all A high index of suspicion is necessary It carries a great deal of misunderstanding and stigma Usually higher % of those utilizing Health Care services
6 Objectives Upon completion of this educational activity, you will be better able to: Discuss tolerance to drugs with patients competently Ask the right questions for Addiction risk assessment Learn ways patients can con and manipulate prescribers
7 Doctor, please, some more of these Outside the door, she took four more What a drag it is getting old. The Rolling Stones Mother s Little Helpers
8 We ve become a Nation of Pill Takers
9 Diversion of Rx Drugs of Abuse is now considered the number 1 public health issue - CDC If Rx Drug Use tracts similar to Alcohol Use, then approximately 50% of all Rx Opiates, Sedatives and Stimulants are diverted or otherwise abused
10 To write a prescription is easy, but to come to an understanding with people is hard. ~Franz Kafka A Country Doctor,1919
11 Usual Way of Discussing Addiction Issues Never ask- Probably most common Do you have a drinking or drug Problem? Or You don t have a drinking or drug problem do you? How much do you drink or use drugs?
12 Patient Satisfaction Survey anyone
13 Keep everyone Happy
14 The Primary Risk Factors for Addiction Inheritance Age of first use Availability of addictive substances
15 Primary Drugs of Addiction Alcohol- always the most common Opioids* Benzodiazepines/ Z-drugs Cannabis and Cocaine Amphetamines (includes other stimulants like methylphenidate) *(Tramadol is an Opioid!)
16 The Willingway Drug Rule When old drugs become addictive, they are replaced with new nonaddictive drugs. When the new drugs become addictive, they are replace by new non-addictive drugs. Adapted from the Recovery Book by Al Mooney, MD
17 Dopamine Pathways Pleasure pathways striatum frontal cortex hippocampus alcohol substantia nigra/vta cocaine heroin nicotine amphetamines opiates THC PCP ketamine nucleus accumbens heroin alcohol benzodiazepines barbiturates
18 What I do Ask different questions And in the course of my usual History taking Any hint of judgmental or disapproving attitude and the useful conversation is over
19 Won t they just lie to me Well they can and do sometimes But you ll never know unless you ask You ll get a lot of information either way
20 My 1 st law of Addiction Medicine Denial is proportional to the obvious and measurable damage done by drinking or drug use *Corollary- Denial increases if confronted with the evidence
21 My 2 nd law of Addiction Medicine There is an inverse and proportional relationship between the degree of conviction a person has in their dx and the likelihood it actually exists
22 How I Ask Don t make a Big Deal out of it Include it as part of the overall conversation Make sure the person understands you are not judging you just need accurate information to care for them
23 What to Ask Ask do you drink? Use Rx or Recreational drugs? When was the last time you. Are you concerned about your drinking or drug use? Have you considered doing something different with your drinking or drug use? Ever have times you drank or used more than you intended too?
24 Then. How old were you when you first used alcohol or another drug? Any of your family members having issues with alcohol or other drugs? How many times in the past year have you had 5 or more drinks in a day? (4 for women) Ever Used to get high in past year?
25 The Face of Pain
26 Pain Management vs. Patient Management Acute Pain Chronic Pain The Patient with the Pain
27 What about Pain? Acute Pain- Usually obvious pathology or condition Acute is usually less than 3 months Chronic Pain- Often no obvious pathology Over 3 to 6 months duration
28 Acute vs. Chronic Pain
29 Dental Procedures Surgery Injuries Acute Pain If no Addiction history or concerning History- Treat adequately and for enough time If Addiction History- May need more aggressive, but very short duration Tx
30 Chronic Pain Ask what is the pain preventing them from doing? Not How bad is the pain? Pain scales are not helpful. Ask about things they are able to do.
31 Institutionalization of Pain
32 New Non-medical Users of Pain Relievers Thousands of New Users 3,000 2,500 All Ages 2,000 1,500 1,000 Over 18 Under Source: 2003 NSDUH, SAMHSA
33 Opioid Prescriptions Soar Between 1999 and 2002: Oxycodone Rx s increased 50% to 29 million Fentanyl Rx s increased 150% to 4.6 million Morphine Rx s increased 60% to 3.8 million
34 Hydrocodone USA uses 99% of the entire world production
35 More about Pain Ask how they first came to have the pain. Ask how long the pain has been present. Ask about prior evaluations. Ask about prior treatment.
36
37 Smoking and Chronic Pain: Weingarten et al Mayo Clinic March 2011 Smoking is a risk factor for chronic pain Smokers with chronic pain indicate that their pain is more intense Pain activates the sympathetic nervous system and the (HPA) axis The HPA system is altered in smokers
38 Red Flags The Call Brand Anytime they mention or ask for a specific drug by name Having more than one prescriber. Using more than one pharmacy.
39 Red Flags Being on more than one class of controlled substance. They brought their films or old records. Work or disability related.
40 So you are about to Rx a controlled substance
41 Use your State s Rx Monitoring Program! How many classes of drugs How many prescribers Overlapping Rx s How many Pharmacies Amount and frequency
42 KASPER Case Study 3 (Page 1) - Male Patient Date Filled Drug Name Qty Days Prescriber Name Prescriber City Pharmacy Name Pharmacy City 02/01/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy AA Ashland 02/02/2010 Alprazolam 0.25MG Doctor AA Ashland Pharmacy BB Ashland 02/10/2010 Oxycodone Hcl 30MG Doctor BB Wheelersburg Pharmacy CC Ashland 02/10/2010 Oxycontin 40MG Doctor BB Wheelersburg Pharmacy CC Ashland 02/22/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy AA Ashland 03/09/2010 Oxycodone Hcl 30MG Doctor BB Wheelersburg Pharmacy CC Ashland 03/09/2010 Oxycontin 40MG Doctor BB Wheelersburg Pharmacy CC Ashland 03/10/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy AA Ashland 03/29/2010 Alprazolam 0.25MG Doctor AA Ashland Pharmacy AA Ashland 03/29/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy AA Ashland 04/07/2010 Oxycodone Hcl 30MG Doctor BB Wheelersburg Pharmacy CC Ashland 04/07/2010 Oxycontin 40MG Doctor BB Wheelersburg Pharmacy CC Ashland 04/20/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy AA Ashland 05/02/2010 Alprazolam 0.25MG Doctor AA Ashland Pharmacy BB Ashland 05/02/2010 Oxazepam 30MG Doctor AA Ashland Pharmacy BB Ashland 05/04/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy DD Ashland 05/06/2010 Oxycodone Hcl 30MG Doctor BB Wheelersburg Pharmacy CC Ashland 05/10/2010 Oxycontin 40MG Doctor BB Wheelersburg Pharmacy CC Ashland 05/12/2010 Alprazolam 1MG Doctor CC Wheelersburg Pharmacy EE Ashland 05/12/2010 Oxycodone Hcl 15MG Doctor BB Wheelersburg Pharmacy EE Ashland 05/12/2010 Oxycodone Hcl 30MG Doctor CC Wheelersburg Pharmacy EE Ashland 05/12/2010 Oxycontin 40MG Doctor CC Wheelersburg Pharmacy EE Ashland 05/25/2010 Alprazolam 0.25MG Doctor AA Ashland Pharmacy BB Ashland 05/26/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy DD Ashland 06/02/2010 Oxycodone Hcl 30MG Doctor BB Wheelersburg Pharmacy CC Ashland 06/02/2010 Oxycontin 40MG Doctor BB Wheelersburg Pharmacy CC Ashland 06/10/2010 Alprazolam 1MG 7 7 Doctor CC Wheelersburg Pharmacy EE Ashland 06/10/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy AA Ashland 06/10/2010 Oxycodone Hcl 15MG 28 7 Doctor CC Wheelersburg Pharmacy EE Ashland 06/10/2010 Oxycodone Hcl 30MG 56 7 Doctor CC Wheelersburg Pharmacy EE Ashland 06/10/2010 Oxycontin 40MG 14 7 Doctor CC Wheelersburg Pharmacy EE Ashland
43 KASPER Case Study 3 (Page 2) - Male Patient Date Filled Drug Name Qty Days Prescriber Name Prescriber City Pharmacy Name Pharmacy City 06/15/2010 Alprazolam 0.5MG Doctor AA Ashland Pharmacy BB Ashland 06/15/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy BB Ashland 06/22/2010 Alprazolam 1MG Doctor CC Wheelersburg Pharmacy EE Ashland 06/22/2010 Oxycodone Hcl 15MG Doctor CC Wheelersburg Pharmacy EE Ashland 06/22/2010 Oxycodone Hcl 30MG Doctor CC Wheelersburg Pharmacy EE Ashland 06/22/2010 Oxycontin 40MG Doctor CC Wheelersburg Pharmacy EE Ashland 06/30/2010 Oxycodone Hcl 30MG Doctor BB Wheelersburg Pharmacy CC Ashland 06/30/2010 Oxycontin 40MG Doctor BB Wheelersburg Pharmacy CC Ashland 07/06/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy BB Ashland 07/20/2010 Alprazolam 0.5MG Doctor AA Ashland Pharmacy BB Ashland 07/21/2010 Alprazolam 0.5MG Doctor AA Ashland Pharmacy AA Ashland 07/21/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy AA Ashland 07/22/2010 Alprazolam 1MG Doctor CC Wheelersburg Pharmacy EE Ashland 07/22/2010 Oxycodone Hcl 15MG Doctor CC Wheelersburg Pharmacy EE Ashland 07/22/2010 Oxycodone Hcl 30MG Doctor CC Wheelersburg Pharmacy EE Ashland 07/22/2011 Oxycodone Hcl 30MG Doctor CC Wheelersburg Pharmacy EE Ashland 07/22/2010 Oxycontin 40MG Doctor CC Wheelersburg Pharmacy EE Ashland 07/29/2010 Oxycodone Hcl 30MG Doctor BB Wheelersburg Pharmacy CC Ashland 07/29/2010 Oxycontin 40MG Doctor BB Wheelersburg Pharmacy CC Ashland 08/18/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy AA Ashland 08/19/2010 Alprazolam 1MG Doctor CC Wheelersburg Pharmacy EE Ashland 08/19/2010 Oxycodone Hcl 15MG Doctor CC Wheelersburg Pharmacy EE Ashland 08/19/2010 Oxycodone Hcl 30MG Doctor CC Wheelersburg Pharmacy EE Ashland 08/19/2010 Oxycodone Hcl 30MG Doctor CC Wheelersburg Pharmacy EE Ashland 08/19/2010 Oxycontin 40MG Doctor CC Wheelersburg Pharmacy EE Ashland 08/24/2010 Alprazolam 0.5MG Doctor AA Ashland Pharmacy AA Ashland 08/26/2010 Oxycodone Hcl 30MG Doctor BB Wheelersburg Pharmacy CC Ashland 08/26/2010 Oxycontin 40MG Doctor BB Wheelersburg Pharmacy CC Ashland 09/08/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy BB Ashland
44 KASPER Case Study 3 (Page 3) - Male Patient Date Filled Drug Name Qty Days Prescriber Name Prescriber City Pharmacy Name Pharmacy City 09/16/2010 Oxycodone Hcl 15MG Doctor CC Wheelersburg Pharmacy EE Ashland 09/16/2010 Oxycodone Hcl 30MG Doctor CC Wheelersburg Pharmacy EE Ashland 09/16/2010 Oxycontin 40MG Doctor CC Wheelersburg Pharmacy EE Ashland 09/23/2010 Oxycodone Hcl 30MG Doctor BB Wheelersburg Pharmacy CC Ashland 09/23/2010 Oxycontin 40MG Doctor BB Wheelersburg Pharmacy CC Ashland 10/13/2010 Alprazolam 1MG Doctor CC Wheelersburg Pharmacy EE Ashland 10/13/2010 Oxycontin 40MG Doctor CC Wheelersburg Pharmacy EE Ashland 10/19/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy BB Ashland 10/20/2010 Oxycodone Hcl 30MG Doctor BB Wheelersburg Pharmacy CC Ashland 10/20/2010 Oxycontin 40MG Doctor BB Wheelersburg Pharmacy CC Ashland 11/17/2010 Oxycodone Hcl 30MG Doctor BB Wheelersburg Pharmacy EE Ashland 11/17/2010 Oxycontin 40MG Doctor BB Wheelersburg Pharmacy EE Ashland 11/22/2010 Alprazolam 2MG Doctor DD Port Charlotte Pharmacy CC Ashland 11/22/2010 Endocet 325MG/10MG Doctor DD Port Charlotte Pharmacy CC Ashland 11/22/2010 Oxycodone Hcl 30MG Doctor DD Port Charlotte Pharmacy CC Ashland 12/13/2010 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy AA Ashland 12/15/2010 Oxycodone Hcl 30MG Doctor BB Wheelersburg Pharmacy EE Ashland 12/15/2010 Oxycontin 40MG Doctor BB Wheelersburg Pharmacy EE Ashland 01/07/2011 Hydrocodone/Acetaminophen 650MG/10MG Doctor AA Ashland Pharmacy AA Ashland 01/10/2011 Oxazepam 30MG Doctor AA Ashland Pharmacy BB Ashland 01/16/2011 Alprazolam 0.5MG Doctor AA Ashland Pharmacy BB Ashland
45 If you are Prescribing Chronically Use your states Prescription Monitoring Obtain random Drug screens and for cause testing Have a Contract they sign- lots are available or build your own Do pill counts randomly- so have them bring their bottles
46 What about Tolerance? Well doc I just have a big tolerance, that s why my dose has gotten so big. Ask how long they have been on the drug. There is really only one way to develop tolerance. Our natural instinct is to be helpful. Don t let that get in the way of good care.
47 Opiate Tolerance and Hyperalgesia apparent opioid tolerance is not synonymous with pharmacological tolerance-may be the first sign of opioidinduced pain sensitivity suggesting a need for opioid dose reduction. repeated opioid administration could lead to a progressive and lasting reduction of baseline nociceptive thresholds, hence an increase in pain sensitivity. Mao et al, Pain, 100 (2002)
48 Opioid Induced Hyperalgesia
49 Mark Twain: "It ain't what you don't know that gets you into trouble. It's what you know for sure that just ain't so."
50 The Other Guy Did It
51 Providers Clinical Support System for Opioid Therapies (PCSS-O) Providers Clinical Support System for Opioid Therapies (PCSS-O) is a collaborative project led by American Academy of Addiction Psychiatry with: American Dental Association, American Medical Association, American Osteopathic Academy of Addiction Medicine, American Psychiatric Association, American Society for Pain Management Nursing, and International Nurses Society on Addictions. Goal: To develop evidence-based educational resources (webinars, online modules and listserv) offered at no cost to health professionals in the treatment of chronic pain and/or opioid related addiction. For more information, please visit:
Sample Patient Agreement Forms
Sample Patient Agreement Forms Introduction This resource includes two sample patient agreement forms that can be used with patients who are beginning long-term treatment with opioid analgesics or other
The Heroin Epidemic in Adolescents and Young Adults. Marla D. Kushner, DO, FACOFP, FASAM, FSAHM AOAAM February 25, 2015
The Heroin Epidemic in Adolescents and Young Adults Marla D. Kushner, DO, FACOFP, FASAM, FSAHM AOAAM February 25, 2015 1 Marla Kushner, DO, Disclosures Speaker Bureau Alkermes Reckitt Benckiser 2 TARGET
Peer Assistance and Opioid Dependency. Disclosures
Peer Assistance and Opioid Dependency Suzanne Kinkle, RN, BS, CARN Director - Recovery and Monitoring Program (RAMP) New Jersey State Nurses Association Al Rundio PhD, DNP, RN, APRN, NEA-BC, DPNAP Associate
Young Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers
Young Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers Audio will begin at 2:00 PM ET. You can listen through your computer
PRESCRIPTION PAINKILLER OVERDOSES
IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky
Opioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
How To Get A Prescription In Rhode Island
Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures
Southlake Psychiatry. Suboxone Contract
Suboxone Contract Thank you for considering Southlake Psychiatry for your Suboxone treatment. Opiate Addiction is a serious condition for which you may find relief with Suboxone treatment. In order to
The Changing Face of Opioid Addiction:
9th Annual Training and Educational Symposium September 6, 2012 The Changing Face of Opioid Addiction: A Review of the Research and Considerations for Care Mark Stanford, Ph.D. Santa Clara County Dept
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,
2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov
OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion
An integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009 Background Defining the problem: Opiates pain relievers (OxyContin,
Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth
Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us
Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain (CNCP)
Appendix D: Urine Drug Testing for Monitoring Opioid Therapy i. Monitoring opioid therapy with urine drug testing (UDT) ii. UDT algorithm for monitoring opioid therapy iii. UDT clinical vignettes iv. Frequently
Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended. (1) by striking clause (ii) and inserting the following:
Section XX. Definitions. Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended (1) by striking clause (ii) and inserting the following: (ii) The term qualifying practitioner
Prescription Medication Abuse: Skills for Prevention and Intervention
Prescription Medication Abuse: Skills for Prevention and Intervention icare Partnership www.icarenc.org James Finch, MD North Carolina Society of Addiction Medicine NC Governor s Institute on Alcohol and
These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level.
Substance-Related Disorders DSM-V Many people use words like alcoholism, drug dependence and addiction as general descriptive terms without a clear understanding of their meaning. What does it really mean
Jane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture
Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational
Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District
Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP
EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.
Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF
American Indian Health Commission for Washington State October 1, 2015
American Indian Health Commission for Washington State October 1, 2015 States with more opioid pain reliever sales tend to have more drug overdose deaths Death rate, 2011, National Vital Statistics System.
Medical Cannabis and Addictions. October 2015 Charlie Reznikoff
Medical Cannabis and Addictions October 2015 Charlie Reznikoff Medical Cannabis Topics Is marijuana addictive? Is medical cannabis addictive? Will medical cannabis lead to increased adolescent use of recreational
After seeing a patient on a Diversion Alert installment..
After seeing a patient on a Diversion Alert installment.. Recommendations from Dr. James Berry of Mercy Recovery Center OVERVIEW OF DIVERSION Manufacture Distribution Pharmacy Patient End -user OPPORTUNITIES
Drug Testing to Support Pain Management
NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of
Brian Johnson M.D. Associate Professor Psychiatry/Anesthesia SUNY Upstate Member Boston Psychoanalytic Society
Brian Johnson M.D. Associate Professor Psychiatry/Anesthesia SUNY Upstate Member Boston Psychoanalytic Society Receptors: Mu, Delta, Kappa, Nociceptin Mu agonist goal of use Routes of administration Eating
2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California
2015 OPSC Annual Convention syllabus February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California FRIDAY, FEBRUARY 6, 2015: 9:30am - 10:30am Opioid Addiction and Buprenorphine Use * Presented by
SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources
SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services Administration 1 Overview National
Pharmacology and Physiology (C105) Understanding Pharmacology and Physiology. The History of Drugs. The Neurobiology of Addiction.
Understanding Pharmacology and Physiology Knowledge of Pharmacology and Physiology is Crucial SAMHSA s Counselor Competencies What is Addiction? NIDA: Why Do People Use Drugs? From Abuse to Addiction Desired
SAFE PAIN MEDICATION PRESCRIBING GUIDELINES
Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses
Prescription Drug Abuse in the Workplace
Prescription Drug Abuse in the Workplace Illicit drugs and misuse of alcohol are not the only substances that can affect health and safety in workplaces. Prescription drugs, when used without a prescription
Magee-Womens Hospital
Magee-Womens Hospital Magee Pregnancy Recovery Program: History Pregnancy Recovery Center A Medical Home Model Approach to Strengthen Families Bawn Maguire, MSN, RN Programmatic Nurse Specialist Stephanie
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB
Disclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu. The West Virginia Model
West Virginia University School of Medicine BEHAVIORAL MEDICINE & PSYCHIATRY Morgantown, WV Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu Disclosure Reckitt Benckiser
Understanding Your Pain
Toll Free: 800-462-3636 Web: www.endo.com Understanding Your Pain This brochure was developed by Margo McCaffery, RN, MS, FAAN, and Chris Pasero, RN, MS, FAAN authors of Pain: Clinical Manual (2nd ed.
Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
Opioid Agreement for Center for Pain Management S.C.
Opioid Agreement for Center for Pain Management S.C. Patient Name: DOB: I am the patient named above. I have agreed to use pain medication as part of my treatment for chronic pain. I understand that these
Outcomes for Opiate Users at FRN Facilities. FRN Research Report September 2014
Outcomes for Opiate Users at FRN Facilities FRN Research Report September 2014 Introduction The illicit use of opioids has reached epidemic proportions in the United States (Alford, 2007; Meges et al,
Opiates Heroin/Prescription Steve Hanson Opiates Dates to 4,000 BC Mimics endorphin activity Natural - Opium, morphine, codeine Semi-synthetic- Heroin, Dilaudid Synthetics - Darvon, Demerol, Fentanyl Modern
TEENS AND PRESCRIPTION DRUGS An Analysis of Recent Trends on the Emerging Drug Threat
TEENS AND PRESCRIPTION DRUGS An Analysis of Recent Trends on the Emerging Drug Threat OFFICE OF NATIONAL DRUG CONTROL POLICY EXECUTIVE OFFICE OF THE PRESIDENT FEBRUARY 2007 TABLE OF CONTENTS Introduction
Treatment of Prescription Opioid Dependence
Treatment of Prescription Opioid Dependence Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse McLean Hospital, Belmont, MA Professor of Psychiatry, Harvard Medical School, Boston, MA Prescription
Screening Patients for Substance Use in Your Practice Setting
Screening Patients for Substance Use in Your Practice Setting Learning Objectives By the end of this session, participants will Understand the rationale for universal screening. Identify potential health
KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE
KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.
Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management
Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management Dr. Barbara Krantz Medical Director Diplomate American Board of Addiction Medicine 1 Learning Objectives
SUBOXONE /VIVITROL WEBINAR. Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12
SUBOXONE /VIVITROL WEBINAR Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12 WEBINAR INTRODUCTIONS Cynthia Parsons- Program Manager
Marijuana: The changing public opinion 5/12/2014. Mother s little helper: Prescription drug abuse in the 21 st century
Mother s little helper: Prescription drug abuse in the 21 st century Carol Falkowski CEO and Founder Drug Abuse Dialogues St. Paul, Minnesota www.drugabusedialogues.com More kids smoke marijuana than smoke
This is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics
This is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics Welcome to Mayo Medical Laboratories Hot Topics. These presentations provide short discussion
Information for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
FRN Research Report February/March 2012: Treatment Outcomes for Prescription Drug Addiction at Michael s House
FRN Research Report February/March 2012: Treatment Outcomes for Prescription Drug Addiction at Michael s House Background While the use of illegal drugs like cocaine and heroin is falling, more people
Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008
PRESCRITPION DRUG ABUSE: AN EPIDEMIC What is Addiction? By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Addiction is a primary, chronic disease
Prescription for Danger
Prescription for Danger A Report on the Troubling Trend of Prescription and Over-the-Counter Drug Abuse Among the Nation s Teens OFFICE OF NATIONAL DRUG CONTROL POLICY EXECUTIVE OFFICE OF THE PRESIDENT
INFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People
Product No. 2002-L0424-004 INFORMATION BRIEF AUGUST 2002 U. S. D E P A R T M E N T O F J U S T I C E NDIC and Stockbyte Overview Prescription drugs, a category of psychotherapeutics that comprises prescription-type
TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013
2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,
Opioids and the Injured Worker Tools for Successful Outcomes
Opioids and the Injured Worker Tools for Successful Outcomes Tim Pokorney, RPh Director, Clinical Express Scripts Workers' Compensation Division Goals and Objectives Alarming statistics for narcotic utilization,
Populations at risk for opioid overdose
Populations at risk for opioid overdose Len Paulozzi, MD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention April
Getting the best result from Opioid medicine. in the management of chronic pain
Getting the best result from Opioid medicine in the management of chronic pain Your doctor has prescribed you opioid medicine to help you manage your chronic pain. This patient information leaflet gives
A Report on Marijuana and Prescription Drugs
Prescription Drug Misuse in America A Report on Marijuana and Prescription Drugs Table of Contents Summary 2 Prescription Drug Misuse is Prevalent 6 Marijuana: The Most Misused Drug 8 Recreational Marijuana
Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence
Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction
Heroin Addiction. Kim A. Drury RN, MSN
Heroin Addiction Kim A. Drury RN, MSN Heroin use is on the rise in our area. Nearly every day the news media reports situations involving Heroin. According to the Substance Abuse and Mental Health Services
Substance Use: Addressing Addiction and Emerging Issues
MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population
San Mateo County Alcohol and Other Drug Services New Medication Policy
San Mateo County Alcohol and Other Drug Services New Medication Policy Implementation, Implications, and Strategies for Success Brian Greenberg, Ph.D. Lea Goldstein, Ph.D. Staff Training January 2008 SMC
3/27/2012. Supply and Demand: The Substance Abuse/Misuse Market Triangle
Substance Abuse and Misuse: A Tragic Market That Can Be Curtailed Tennessee Department of Health Protect, promote, and improve the health and prosperity of persons in the State of Tennessee. John J. Dreyzehner,
Transitioning Chronic Pain Patients Out of the Hospital. Rosemary Quirk, MD, DTMH ACP, November 7, 2014
Transitioning Chronic Pain Patients Out of the Hospital Rosemary Quirk, MD, DTMH ACP, November 7, 2014 Patients rate baseline chronic pain between 4/10-8/10 on clinic surveys This fact should fundamentally
Pain and problem drug use
Pain and problem drug use Information for patients Prepared by the British Pain Society in consultation with the Royal College of Psychiatrists, the Royal College of General Practitioners and the Advisory
Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices
Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices National Governors Association Policy Academy: Reducing Prescription Drug Abuse June 8, 2015 Burlington, VT Improving Interstate
The Current State of Drug Abuse Across the Nation. December 12, 2015
The Current State of Drug Abuse Across the Nation December 12, 2015 Agenda The Partnership for Drug-Free Kids The macro picture Opioid abuse and addiction What can we do about it? Moving upstream: connecting
ADDICTIONS. BEHAVIOURAL Internet Shopping Work Sex Gambling Food. SUBSTANCE - RELATED Alcohol Drugs Medicine Tobacco
ADDICTIONS BEHAVIOURAL Internet Shopping Work Sex Gambling Food SUBSTANCE - RELATED Alcohol Drugs Medicine Tobacco Addiction is a chronic, relapsing disease affecting the brains's reward, motivation and
What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine.
What you should know about treating your pain with opioids Important information on the safe use of opioid pain medicine. If your healthcare provider has determined that opioid therapy is right for you,
Striking a Balance: a provider perspective. kpfeifer@chcf.org
Striking a Balance: a provider perspective kpfeifer@chcf.org Beth s story 38 years old, erratically employed Counseling doesn t help Chronic low back pain after car accident 8 Vicodin/day grew to 180 mg
Arkansas Emergency Department Opioid Prescribing Guidelines
Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular
02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION
Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE
Assessment and Diagnosis of DSM-5 Substance-Related Disorders
Assessment and Diagnosis of DSM-5 Substance-Related Disorders Jason H. King, PhD (listed on p. 914 of DSM-5 as a Collaborative Investigator) j.king@lecutah.com or 801-404-8733 www.lecutah.com D I S C L
PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications
PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications Primary Care & Specialist Prescribing Guidelines Introduction Partnership HealthPlan is a County Organized Health System covering
Heroin Addiction and Overdose: What Can We Do to Address This Growing Problem? Nora D. Volkow, M.D. Director
Heroin Addiction and Overdose: What Can We Do to Address This Growing Problem? Nora D. Volkow, M.D. Director Illicit Drugs Marijuana Prescription Drug Misuse/Abuse is a Major Problem in the US Current
Title: Opening Plenary Session Challenges and Opportunities to Impact the Opioid Dependence Crisis
The American Association for the Treatment of Opioid Dependence, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org,
Appropriate Use of UDT to Improve Patient Care
Published on OpioidRisk (http://www.opioidrisk.com) Home > Urine Drug Testing Urine Drug Testing This guide provides: Download Entire Guide [1] Appropriate use of Urine Drug Testing (UDT) to improve patient
Alcoholism, Drug Addiction, and the Road to Recovery
Alcoholism, Drug Addiction, and the Road to Recovery Life on the Edge Barry Stimmel, MD The Haworth Medical Press An Imprint of The Haworth Press, Inc. New York London Oxford CONTENTS Preface Acknowledgments
Office-based Treatment of Opioid Dependence with Buprenorphine
Office-based Treatment of Opioid Dependence with Buprenorphine David A. Fiellin, M.D Professor of Medicine, Investigative Medicine and Public Health Yale University School of Medicine Dr. Fiellin s Disclosures
Impact of Systematic Review on Health Services: The US Experience
Impact of Systematic Review on Health Services: The US Experience Walter Ling MD Integrated Substance Abuse Programs (ISAP) UCLA The effectiveness of interventions for addictions: The Drug and Alcohol
Table of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9
Table of Contents I. Introduction... 2 II. Summary... 3 III. Charts A. Total Drug Intoxication Deaths... 5 B. Opioid-Related Deaths... 9 C. Heroin-Related Deaths... 11 D. Prescription Opioid-Related Deaths...
Substance Abuse Prevention
Prescription Drug Abuse Prevention & -Early Intervention (SBIRT) Barry R. Donovan, Ph.D. NYS OASAS Bureau of Prevention Services Research Application Unit Substance Abuse Prevention What do Heroin, Rx
Prescription Drug Abuse Prevention & -Early Intervention (SBIRT)
Prescription Drug Abuse Prevention & -Early Intervention (SBIRT) Barry R. Donovan, Ph.D. NYS OASAS Bureau of Prevention Services Research Application Unit Substance Abuse Prevention What do Heroin, Rx
What Parents Need to Know
What Parents Need to Know About Prescription Drug Abuse Office of District Attorney Jonathan W. Blodgett A Message From the District Attorney Prescription drug abuse is a growing problem. According to
Visit www.takebackmylife.org to hear more of my story or call 211 for help and treatment options
In high school, I experimented with alcohol and pot. Then I moved on to narcotics and cocaine, which landed me in jail several times. By 25, I was a daily heroin user with a long-term prison sentence.
Judith Martin, MD Medical Director, Substance Abuse Services, San Francisco DPH
Western Occupational & Environmental Medical Association CME Webinar April 17, 2013 Judith Martin, MD Medical Director, Substance Abuse Services, San Francisco DPH PLEASE STAND BY - WEBINAR WILL BEGIN
Opioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment
Opioids for Chronic Pain and Addiction Treatment Joseph Merrill M.D., M.P.H. University of Washington February 24, 2012 Outline for Today Opioids for pain treatment Trends Problems High dose prescribing
Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium
Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of Medicine tvp@case.edu
ALCOHOL AND DRUG USE ASSESSMENT
ASSIST (Alcohol, Smoking and Substance Involvement Screening Test) Source: The items are from the ASSIST Scale. Public Domain Reference: WHO ASSIST Working Group (2002). The Alcohol, Smoking and Substance
NEUROPHARMACOLOGY AND ADDICTION CHRISTOPHER M. JONES, PHARMD, MPH
NEUROPHARMACOLOGY AND ADDICTION CHRISTOPHER M. JONES, PHARMD, MPH Disclosures This presentation does not represent the views of the US Public Health Service or the US Food and Drug Administration The majority
Alcohol & Chemical Dependence. Chisoo Choi, M.D. Internal Medicine Consultant Brookhaven Hospital Tulsa, Oklahoma
Alcohol & Chemical Dependence Chisoo Choi, M.D. Internal Medicine Consultant Brookhaven Hospital Tulsa, Oklahoma Objectives Increased awareness of alcohol and chemical dependence problems Hallmarks of
Iowa Governor s Office of Drug Control Policy
Talking to kids about {prescription drug abuse Iowa Governor s Office of Drug Control Policy Talking to kids about {prescription drug abuse As a parent you re concerned about your children s health and
Alcohol Overuse and Abuse
Alcohol Overuse and Abuse ACLI Medical Section CME Meeting February 23, 2015 Daniel Z. Lieberman, MD Professor and Vice Chair Department of Psychiatry George Washington University Alcohol OVERVIEW Definitions
Prescription Drug Abuse and NASPER Harold Rogers Prescription Drug Monitoring Program June 30, 2010 Washington, DC
Prescription Drug Abuse and NASPER Harold Rogers Prescription Drug Monitoring Program June 30, 2010 Washington, DC Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services
Prescription Painkiller/Heroin Addiction and Treatment: Public and Patient Perceptions
Prescription Painkiller/Heroin Addiction and Treatment: Public and Patient Perceptions Highlights conducted by Schulman, Ronca, & Bucuvalas, Inc. 8403 Colesville Road, Suite 820 Silver Spring, Maryland
Frequently asked questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs
Medication is not a part of treatment.
Medication is not a part of treatment. Medication can be an effective part of treatment. Medication is used in the treatment of many diseases, including addiction. Medical decisions must be made by trained
Managing drug-seeking behavior
Managing drug-seeking behavior Miriam Komaromy, MD Medical Director UNM Project ECHO Addiction Treatment Program The $10,000 question Why is the patient seeking the drugs? The problem: Only the patient
Opioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA
Opioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA American Academy of Hospice and Palliative Care Medicine October,
Effective Treatment Strategies for Adolescent Heroin and Opiate Use. Chris Gleason, MA, CAADC, MAATP Director Rosecrance McHenry County
Effective Treatment Strategies for Adolescent Heroin and Opiate Use Chris Gleason, MA, CAADC, MAATP Director Rosecrance McHenry County Learning Objectives The unique challenges related to clinical work
Addictions: Why Don t They Just Quit?
Counseling Center of New Smyrna Beach 265 N. Causeway New Smyrna Beach FL 32169 Ph: 386-423-9161 Fax: 386-423-3094 Addictions: Why Don t They Just Quit? By Shane Porter One of the most frustrating issues